Viewing Study NCT00936832


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2025-12-31 @ 7:11 AM
Study NCT ID: NCT00936832
Status: WITHDRAWN
Last Update Posted: 2022-08-30
First Post: 2009-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery
Sponsor: Federation Francophone de Cancerologie Digestive
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CDR0000637832
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators